JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders.

Suppr

超能文献

作者信息

Ohyashiki K, Aota Y, Akahane D, Gotoh A, Ohyashiki J H

出版信息

Leukemia. 2007 May;21(5):1097-9. doi: 10.1038/sj.leu.2404604. Epub 2007 Feb 22.

DOI:10.1038/sj.leu.2404604

PMID:17315023

Abstract

摘要

相似文献

JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders.

Leukemia. 2007 May;21(5):1097-9. doi: 10.1038/sj.leu.2404604. Epub 2007 Feb 22.

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

Cancer. 2006 Nov 1;107(9):2206-11. doi: 10.1002/cncr.22240.

A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.

Am J Clin Pathol. 2007 Jun;127(6):977-81. doi: 10.1309/1U61JVXTLPPQ7YP1.

[The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].

Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2109-12.

[Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].

Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):105-9.

Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations.

Hum Pathol. 2006 Nov;37(11):1458-64. doi: 10.1016/j.humpath.2006.05.006. Epub 2006 Jul 26.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Orv Hetil. 2006 Nov 12;147(45):2175-9.

JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.

Pathol Biol (Paris). 2011 Aug;59(4):e89-92. doi: 10.1016/j.patbio.2009.06.005. Epub 2009 Nov 24.

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

Leuk Res. 2008 Mar;32(3):421-7. doi: 10.1016/j.leukres.2007.07.003. Epub 2007 Aug 14.

Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection.

Cancer Genet Cytogenet. 2007 Nov;179(1):19-24. doi: 10.1016/j.cancergencyto.2007.07.008.

引用本文的文献

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.

BMC Med Genet. 2012 Jan 17;13:6. doi: 10.1186/1471-2350-13-6.

Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.

Int J Hematol. 2009 Nov;90(4):522-525. doi: 10.1007/s12185-009-0411-5. Epub 2009 Aug 29.

Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia.

Int J Hematol. 2009 Jan;89(1):39-44. doi: 10.1007/s12185-008-0222-0. Epub 2008 Dec 18.

Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.

Int J Hematol. 2008 May;87(4):446-448. doi: 10.1007/s12185-008-0080-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验